Agios Pharmaceuticals (Germany) Analysis

Agios Stock Analysis Notes

About 99.0% of the company shares are owned by institutions such as pension funds. The company has Price-to-Book (P/B) ratio of 1.62. In the past many companies with similar price-to-book ratios have beat the market. Agios Pharmaceuticals recorded a loss per share of 6.05. The entity had not issued any dividends in recent years. Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology for the treatment of cancer and rare genetic diseases. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is based in Cambridge, Massachusetts. AGIOS PHARMACEUT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 482 people. For more info on Agios Pharmaceuticals please contact Brian MBA at 617 649 8600 or go to https://www.agios.com.

Agios Pharmaceuticals Investment Alerts

Agios Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.39 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Agios Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Agios Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 25th of November, Agios Pharmaceuticals shows the Downside Deviation of 2.83, mean deviation of 2.28, and Risk Adjusted Performance of 0.1154. Agios Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Agios Pharmaceuticals mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation to decide if Agios Pharmaceuticals is priced correctly, providing market reflects its regular price of 52.5 per share.

Agios Pharmaceuticals Price Movement Analysis

Agios Pharmaceuticals Outstanding Bonds

Agios Pharmaceuticals Predictive Daily Indicators

Agios Pharmaceuticals Forecast Models

Agios Pharmaceuticals' time-series forecasting models are one of many Agios Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Agios Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Agios Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Agios shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Agios Pharmaceuticals. By using and applying Agios Stock analysis, traders can create a robust methodology for identifying Agios entry and exit points for their positions.

When running Agios Pharmaceuticals' price analysis, check to measure Agios Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agios Pharmaceuticals is operating at the current time. Most of Agios Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Agios Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agios Pharmaceuticals' price. Additionally, you may evaluate how the addition of Agios Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.